MP pharma plant upgrades delayed

From an American Pharmaceutical Partners, Inc. press release:

SCHAUMBURG, Ill., Aug. 25 /PRNewswire-FirstCall/ -- American
Pharmaceutical Partners, Inc. (Nasdaq: APPX) (APP) today said that its program
to upgrade the facility and equipment and re-validate production conditions at
its Melrose Park, IL manufacturing facility, which is being conducted as part
of the company's routine annual maintenance program, will require more time
than initially anticipated. The upgrading and validation program at APP's
Melrose Park plant is part of a company-wide strategic initiative....
Management currently expects that the Melrose Park facility will be
partially operational by early September and fully operational by late
September, pending successful completion of process simulation runs (media
fills).